Shail M. Govani

Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort

Akbar K. Waljee, Wyndy L. Wiitala, Shail M. Govani et al. · PLoS ONE · 2016 · 170 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning

Akbar K. Waljee, Rachel Lipson, Wyndy L. Wiitala et al. · Inflammatory Bowel Diseases · 2017 · 114 citations · Full text

Computing, Internal Medicine, Clinical Decision Support +16

Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases

Julajak Limsrivilai, Ryan W. Stidham, Shail M. Govani et al. · Clinical Gastroenterology and Hepatology · 2016 · 109 citations · Full text

Public Affairs, Health Care Management, Pharmacoeconomics +14

Predicting corticosteroid‐free endoscopic remission with vedolizumab in ulcerative colitis

Akbar K. Waljee, B. Liu, Kay Sauder et al. · Alimentary Pharmacology & Therapeutics · 2018 · 91 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Combination of thiopurines and allopurinol: Adverse events and clinical benefit in IBD

Shail M. Govani, Peter Higgins · Journal of Crohn s and Colitis · 2010 · 75 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14